Seizure Cluster Care in Epilepsy Monitoring Units Lacks Guidelines

Clinicians at Hackensack Meridian Health are calling for formal guidelines covering the management of seizure clusters that occur during inpatient epilepsy monitoring — a scenario the monitoring unit creates deliberately, yet one that currently lacks a standardized care framework.

The argument is straightforward. Epilepsy monitoring units (EMUs) exist to record seizures. Patients undergo medication tapering, sleep deprivation, and other provocation procedures while scalp video-EEG runs continuously, sometimes for days. The clinical goal is to capture the habitual events that define the patient's epilepsy. But the same provocation that makes diagnosis possible also raises the probability that a patient will seize repeatedly in a short window — a seizure cluster — and that risk sits in tension with the diagnostic mission of the unit.

The Hackensack Meridian Health communication points to a gap: no established, consensus-driven guidelines define how monitoring teams should respond when clusters develop mid-recording. That gap matters for the reading room and the bedside alike. Neurophysiologists reviewing continuous EEG need to know when a run of electrographic events crosses from diagnostically useful into clinically dangerous. Nursing staff and epileptologists need defined thresholds for when to abort the taper, rescue the patient, or end the admission. Without guidelines, those decisions default to local practice and individual judgment, which invites variability from one unit to the next.

Seizure clusters are not a marginal concern in this population. By design, EMU patients are selected because their seizures have been hard to characterize or control in the outpatient setting, and medication withdrawal is a routine part of the protocol. The combination concentrates risk. A cluster in this context is not an unexpected complication — it is a foreseeable consequence of the monitoring strategy itself, which is precisely why the absence of a standardized response framework stands out.

The call for guidelines also touches on a definitional problem that has long complicated cluster research. Published studies of seizure clusters use varying definitions — differing numbers of seizures within differing time windows — making it difficult to compare interventions or quantify incidence across centers. Any guideline effort for the monitoring unit would need to settle on operational criteria: how many electroclinical events over what interval constitute a cluster during continuous video-EEG, and which rescue pathway follows from that determination.

For epilepsy programs, the practical implications are concrete. Units may need to review their tapering protocols, their rescue-medication policies, and their criteria for aborting monitoring. Teams that read intracranial EEG from patients implanted for phase II evaluation face an additional layer, since medication withdrawal in that cohort carries its own risk profile. A guideline framework that distinguishes scalp-EEG monitoring admissions from invasive monitoring admissions would give staff clearer anchors for decisions that currently rest on convention.

The Hackensack Meridian Health communication does not present a new dataset or trial result; it makes a process argument. That argument lands at a moment when monitoring-unit safety more broadly is under scrutiny, including questions about supervision, seizure-abort protocols, and adverse events during provoked recordings. Clusters sit squarely within that safety conversation, and a formal guideline would give programs a reference point for accreditation discussions, protocol writing, and staff training.

What comes next is a consensus process. Professional societies in epilepsy and clinical neurophysiology would be the natural venue for developing cluster-management recommendations specific to the monitoring unit, drawing on existing literature and multicenter practice patterns. Until such guidance arrives, EMU teams will continue to weigh diagnostic yield against seizure burden case by case — which is exactly the variability the Hackensack Meridian Health clinicians want to eliminate.